Randomized Clinical Trial for Ewing Amputation in the VA
Pilot Investigation of Ewing Amputation in Veterans With Peripheral Arterial Disease Undergoing Below Knee Amputation
2 other identifiers
interventional
120
1 country
3
Brief Summary
This study follows the Pilot Investigation of Ewing Amputation for Veterans with PAD Undergoing a Below Knee Amputation. The 2 year pilot feasibility phase has concluded recruitment and enrollment. The current phase is a 5 year randomized study of Ewing Below Knee Amputation vs. Standard Below Knee Amputation. If Veterans participate, they will be randomized to either Ewing Amputation or Standard Below Knee Amputation. The scientific premise motivating this proposal is that Ewing Amputation is a promising surgical technique that may improve walking metrics in dysvascular Veterans by providing a better residual limb and improving pain and balance. In preparation of this proposal, we have formed multi-disciplinary surgical teams at each site, and we have been supported by a clinical trial planning meeting to garner the considerable expertise in rehabilitation and amputee assessment from VA and DOD experts to assist in the design of this proposal, testing the overall hypothesis that: Ewing Amputation can help Veterans walk.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2026
Longer than P75 for not_applicable
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 14, 2022
CompletedFirst Posted
Study publicly available on registry
June 29, 2022
CompletedStudy Start
First participant enrolled
February 2, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 2, 2030
ExpectedStudy Completion
Last participant's last visit for all outcomes
February 2, 2030
February 9, 2026
February 1, 2026
4 years
June 14, 2022
February 4, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (14)
PROMIS Numeric Rating Scale
Patient reported rating scale to assess pain intensity and pain interference.
12 months
Socket Comfort Score
Patient reported rating scale to assess socket fit of prosthesis.
12 months
Phantom and Residual Limb Questionnaire
Patient reported questionnaire to assess sensation in phantom limb.
12 months
Lower Extremity Amputee Data Collection Form
Patient reported questionnaire to assess amputation system of care.
12 months
Lower Limb Mobility Rating Scale
Patient reported scale to assess movement with prosthetic leg.
12 months
Amputee Single Item Mobility Measure
Patient reported measure to assess current level of mobility.
12 months
Activities-specific Balance Scale
Patient reported scale to assess balance while performing every day activities.
12 months
Self-Reported Falls Measure
Patient reported one question survey to calculate falls in the previous month.
12 months
RAND Health Survey
Patient reported survey to assess general health while performing usual activities.
12 months
CRIS Fixed Form Instrument
Patient reported rating scale to assess usual activities in previous two weeks.
12 months
Patient Two Minute Walk Test
To measure distance patient can walk without assistance in 2 minutes.
12 months
Patient Timed Up and Go Test
To measure amount of time patient walks 3 meters.
12 months
Berg Balance Scale
To assess the patient's sitting and standing balance levels.
12 months
Amputee Mobility Predictor Questionnaire
To measure the patient's sitting, standing, turning and walking/stepping with and without prosthesis.
12 months
Study Arms (2)
Ewing Amputation
EXPERIMENTALEwing Below Knee Amputation - incorporates RPNI and AMI
Standard Below Knee Amputation
EXPERIMENTALStandard Below Knee Amputation
Interventions
Ewing Below Knee Amputation - incorporates RPNI and AMI
Eligibility Criteria
You may qualify if:
- Veterans who have reasonable blood flow to heal a TTA (defined as palpable popliteal pulse or palpable femoral pulse with popliteal artery signal)
- Veterans with an expectation of participating in rehabilitation and resuming ambulation after amputation (defined by the Veteran interest, recent ambulation by the Veteran, ability to participate in physical therapy as deemed by the investigators' physical therapy team)
- Veterans who will be undergoing below knee amputation for reasons other than infection (uninfected patients) or Veterans who have had foot infection localized below the ankle (retinaculum uninfected) that has been adequately debrided and treated with appropriate antibiotic course.
You may not qualify if:
- Veterans with end-stage renal disease (ESRD)
- Veterans requiring major amputation due to infection that includes the ankle retinaculum
- Veterans deemed to have inadequate blood flow to heal a TTA
- Veterans who cannot participate in rehabilitation or are not expected to be able to ambulate with a prosthesis for any reason
- Veterans who were randomized for their other limb (to prevent Veteran from the possibility of having 2 different amputations)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Atlanta VA Medical and Rehab Center, Decatur, GA
Decatur, Georgia, 30033-4004, United States
Tennessee Valley Healthcare System Nashville Campus, Nashville, TN
Nashville, Tennessee, 37212-2637, United States
Michael E. DeBakey VA Medical Center, Houston, TX
Houston, Texas, 77030-4211, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Luke P Brewster, MD
Atlanta VA Medical and Rehab Center, Decatur, GA
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- FED
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 14, 2022
First Posted
June 29, 2022
Study Start
February 2, 2026
Primary Completion (Estimated)
February 2, 2030
Study Completion (Estimated)
February 2, 2030
Last Updated
February 9, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share